Cash-Rich SynOx Well Placed To Compete In Hot TGCT Field
Executive Summary
Ono’s just-announced purchase of Deciphera has put the tenosynovial giant cell tumor space under the spotlight and SynOx is making strides to stay at the head of the pack helped by significant financing.